Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

Metsera is aiming to put its weight loss drug MET-097i, which boasts of a longer half-life, through Phase III trials.

She’s racing to a run-through for a 14-course tasting menu she will barely nibble at as she raves about her weight loss on ...